| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/15/2013 | EP2591792A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 05/15/2013 | EP2591786A1 Immunomodulating compositions and uses therefor |
| 05/15/2013 | EP2591099A1 Chimeric clotting factors |
| 05/15/2013 | EP2591094A1 Method of producing recombinant adamts13 in cell culture |
| 05/15/2013 | EP2591041A1 Compositions and methods for increasing poultry hatchability and early performance |
| 05/15/2013 | EP2590998A1 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE |
| 05/15/2013 | EP2590997A2 Stabilized insulinotropic peptides and methods of use |
| 05/15/2013 | EP2590992A2 Mu opioid receptor agonist analogs of the endomorphins |
| 05/15/2013 | EP2590669A2 Treatment of a disease associated with retinal degenerative disorder |
| 05/15/2013 | EP2590668A2 Factor ix polypeptides and methods of use thereof |
| 05/15/2013 | EP2590667A1 Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin |
| 05/15/2013 | EP2590666A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
| 05/15/2013 | EP2590665A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 05/15/2013 | EP2590664A1 Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| 05/15/2013 | EP2590661A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
| 05/15/2013 | EP2590659A2 Gelsolin-enrichment of blood samples through gold particles |
| 05/15/2013 | EP2590643A2 Multi-component pharmaceuticals for treating diabetes |
| 05/15/2013 | EP2590642A2 Pkc activators and anticoagulant in regimen for treating stroke |
| 05/15/2013 | EP2590629A2 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 05/15/2013 | CN103108655A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 05/15/2013 | CN103108654A Multivalent glycopeptide constructs and uses thereof |
| 05/15/2013 | CN103108651A Inhibition of cyp3a drug metabolism |
| 05/15/2013 | CN103108650A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
| 05/15/2013 | CN103108649A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/15/2013 | CN103108648A Romidepsin solid forms and uses thereof |
| 05/15/2013 | CN103108647A Brain function enhancement composition and method for enhancing brain function |
| 05/15/2013 | CN103108646A Composition for improving brain function and method for improving brain function |
| 05/15/2013 | CN103108628A Formulations for infusion of type B lantibiotics |
| 05/15/2013 | CN103108626A Tetranectin-apolipoprotein A-I, lipid particles containing it and its use |
| 05/15/2013 | CN103103244A Walnut blood pressure-lowering active peptide, its preparation method and application |
| 05/15/2013 | CN103103196A Modified goat defensin gene and preparation method and application thereof |
| 05/15/2013 | CN103102418A Fusion protein of granulocyte colony-stimulating factor (G-CSF) as well as mutant of granulocyte colony-stimulating factor (mG-CSF) and human serum albumin 3rd domain (3DHSA) and application |
| 05/15/2013 | CN103102416A Recombinant fusion protein of IL3 and Lidamycin, preparation method and application thereof |
| 05/15/2013 | CN103102406A Continuation - site directed modification of FVIII ? |
| 05/15/2013 | CN103102403A Two mutants of analgesic bioactive peptide GRR, and preparation and application thereof |
| 05/15/2013 | CN103102397A Peptide nucleic acid for prevention and treatment of PCV2 virus and preparation thereof |
| 05/15/2013 | CN103102396A Novel thiostrepton analog, amd preparation method and application thereof |
| 05/15/2013 | CN103102394A B cell epitope peptide PUHI49 for hepatitis c virus (HCV) and application of B cell epitope peptide PUHI49 |
| 05/15/2013 | CN103102393A Polypeptide and application of polypeptide in preparation of drug used for treating depression |
| 05/15/2013 | CN103100092A Application of human cytokine CCDC134 |
| 05/15/2013 | CN103100080A Application of cGP and derivatives in preparation of medicine for inhibiting tumor growth and regeneration |
| 05/15/2013 | CN103100079A Compound medicine for treating infantile diarrhea and preparation method of compound medicine |
| 05/15/2013 | CN103099842A Soft capsule helpful for increasing bone density and preparation method thereof |
| 05/15/2013 | CN103099783A Transdermal delivery nano-preparation, and preparation method and application thereof |
| 05/15/2013 | CN103099777A Bio-enzyme hydrogel taking porous calcium carbonate as carrier and preparation method of bio-enzyme hydrogel |
| 05/15/2013 | CN102429875B Cyclosporin A pulmonary inhaled macroporous microspheres and preparation method thereof |
| 05/15/2013 | CN102258767B Composition for promoting wound healing |
| 05/15/2013 | CN102209530B Orally administrable immunostimulant product for aquaculture |
| 05/15/2013 | CN102178933B Preparation for preventing and treating osteoporosis and osteoarthrosis |
| 05/15/2013 | CN102172394B Application of ciona intestinalis linnaeus peptides |
| 05/15/2013 | CN102167734B Recombinant mutant tenebrio molitor antibacterial peptide and its gene and application |
| 05/15/2013 | CN102060921B High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
| 05/15/2013 | CN101988057B Promoter and application thereof |
| 05/15/2013 | CN101486760B Recombinant protein capable of combining with vascular endothelial cell growth factor and placenta growth factor, as well as preparation method and application thereof |
| 05/15/2013 | CN101351475B Interleukin-12p40 variants with improved stability |
| 05/15/2013 | CN101287831B T-cell receptor and nucleic acid encoding the receptor |
| 05/14/2013 | US8442611 Medical device with reservoir-based sensors |
| 05/14/2013 | US8440882 Methods and compositions for controlling plant pests |
| 05/14/2013 | US8440851 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/14/2013 | US8440795 Kunitz-type recombinant inhibitor |
| 05/14/2013 | US8440794 Peptide sequences, their branched form and use thereof for antimicrobial applications |
| 05/14/2013 | US8440793 Peptide analogs of alpha-melanocyte stimulating hormone |
| 05/14/2013 | US8440792 Antimicrobial peptides and derived metapeptides |
| 05/14/2013 | US8440789 Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator |
| 05/14/2013 | US8440788 N-terminal VDAC variants and uses thereof |
| 05/14/2013 | US8440718 Modulation of inflammation related to columnar epithelia |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440629 Cyclic receptor-associated protein (RAP) peptides |
| 05/14/2013 | US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 05/14/2013 | US8440627 Chimeric polypeptide; a first domain, a first intracellular loop (i1 loop) or a fragment of a G protein coupled receptor, and a second domain, attached to the first domain, a naturally or non-naturally occurring cell-penetrating, membrane-tethering hydrophobic group |
| 05/14/2013 | US8440626 Antineoplastic peptides |
| 05/14/2013 | US8440624 Peptide whitening agents and cosmetic compositions comprising the same |
| 05/14/2013 | US8440623 Polymer stabilized neuropeptides |
| 05/14/2013 | US8440621 Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels |
| 05/14/2013 | US8440620 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 05/14/2013 | US8440619 Utilization of hypertension/hypercardia-preventing effect of D-allose |
| 05/14/2013 | US8440618 Composition for the attachment of implants to collagen or other components of biological tissue |
| 05/14/2013 | US8440617 Hyperbaric treatment in wound healing |
| 05/14/2013 | US8440616 Methods for treatment of insulin-like growth factor-1 deficiency |
| 05/14/2013 | US8440615 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase |
| 05/14/2013 | US8440614 Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein |
| 05/14/2013 | US8440613 Controlling diseases caused by trichomonadida |
| 05/14/2013 | US8440611 Analogues of neuropeptide Y having at least one synthetic amino acid substitution |
| 05/14/2013 | US8440610 Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
| 05/14/2013 | US8440609 Peptides against autoantibodies causing intolerance to cold and use thereof |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440391 used for the direct identification of candidate compounds as receptor agonists, inverse agonists or partial agonists having potential applicability as therapeutic agents |
| 05/14/2013 | US8440234 Standardized bee venom preparation |
| 05/14/2013 | US8440233 Compositions against rotavirus infection and processes for producing the same |
| 05/14/2013 | US8440226 Solvent/polymer solutions as suspension vehicles |
| 05/14/2013 | US8440205 Streptococcal C5A peptidase vaccine |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 05/14/2013 | US8440200 Using hypoallergenic peptide comprising Phl p 6 molecule to desensitize mammalian allergic response to pollen |
| 05/14/2013 | US8440196 Treatment for pancreatitis using IL-6 receptor antagonist antibodies |
| 05/14/2013 | US8440190 Antibody variants |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | US8440184 Compositions of engineered human arginases and methods for treating cancer |
| 05/14/2013 | US8440183 Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof |
| 05/14/2013 | US8440182 Methods and compositions for treating phenylketonuria |